| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 14,027 | 16,541 | 16,723 | 19,689 | | Cost of Revenue | 8,251 | 7,777 | 8,405 | 8,366 | | | Gross Profit | 5,776 | 8,763 | 8,318 | 11,323 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,641 | 7,857 | 8,140 | 7,709 | | Non Recurring | 26,497 | 2,325 |
-
|
-
| | Others | 1,471 | 1,564 | 1,482 | 1,585 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (29,833) | (2,983) | (1,304) | 2,029 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 384 | 263 | 346 | 400 | | Earnings Before Interest And Taxes | (29,449) | (2,720) | (959) | 2,429 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (29,449) | (2,720) | (959) | 2,429 | | Income Tax Expense | 16,227 | (376) | 106 | 126 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (45,676) | (2,345) | (1,065) | 2,303 | | | Non-recurring Events | | Discontinued Operations | 1 | (0) | (3) | (2) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (45,675) | (2,345) | (1,068) | 2,301 | | Preferred Stock And Other Adjustments | (96) | (96) | (96) | (96) | | | Net Income Applicable To Common Shares | ($45,772) | ($2,441) | ($1,164) | $2,205 |
|
0.06% Nasdaq 
Income Statement
